The prostate is still largely assessed by random biopsy, but developments in prostate MRI and fusion with transrectal ultrasonography (TRUS) have made targeted biopsy of the prostate a reality. MRI/TRUS techniques promise to address the issues of overdiagnosis and underdiagnosis in prostate cancer.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Accurate validation of ultrasound imaging of prostate cancer: a review of challenges in registration of imaging and histopathology
Journal of Ultrasound Open Access 30 July 2018
-
A Novel Unsupervised Segmentation Approach Quantifies Tumor Tissue Populations Using Multiparametric MRI: First Results with Histological Validation
Molecular Imaging and Biology Open Access 12 October 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hoeks, C. M. et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. Eur. Urol. 62, 902–909 (2012).
Roethke, M. et al. MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J. Urol. 30, 213–218 (2012).
Haffner, J. et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int. 108, E171–E178 (2011).
Pinto, P. A. et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J. Urol. 186, 1281–1285 (2011).
Rastinehad, A. R. et al. Improving Detection of Clinically Significant Prostate Cancer: Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Guided Prostate Biopsy. J. Urol. 191, 1749–1754 (2014).
Wysock, J. S. et al. A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging-Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial. Eur. Urol. 66, 343–351 (2014).
Sonn, G. A. et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur. Urol. 65, 809–815 (2014).
Rud, E., Baco, E. & Eggesbø, H. B. MRI and ultrasound-guided prostate biopsy using soft image fusion. Anticancer Res. 32, 3383–3389 (2012).
Delongchamps, N. B. et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J. Urol. 189, 493–499 (2013).
Kuru, T. H. et al. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J. Urol. 190, 1380–1386 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Turkbey, B., Choyke, P. A decade in image-guided prostate biopsy. Nat Rev Urol 11, 611–612 (2014). https://doi.org/10.1038/nrurol.2014.273
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.273
This article is cited by
-
Accurate validation of ultrasound imaging of prostate cancer: a review of challenges in registration of imaging and histopathology
Journal of Ultrasound (2018)
-
A Novel Unsupervised Segmentation Approach Quantifies Tumor Tissue Populations Using Multiparametric MRI: First Results with Histological Validation
Molecular Imaging and Biology (2017)
